inner-banner-bg

Current Research in Vaccines Vaccination(CRVV)

ISSN: 2834-880X | DOI: 10.33140/CRVV

Aims and Scope

Journal DOI: 10.33140/CRVV

Current Research in Vaccines & Vaccination (ISSN: 2834-880X) is a peer reviewed open access scientific journal with publish on emerging field of study of vaccinology. The quality of the Editorial Board follows the Peer review process. The time to publish the articles from date of submisison is maximum 30-35 days.

The scope of the journal is research on Adjuvants, AIDS vaccines, Aniimal models, Childhood vaccines, Clinical studies, Clinical Vaccine Studies, Epidemiology, Eukaryotic, CellImmune response to vaccine, Mechanism of immune system, New techniques for vaccines, Prokaryotic cell, Recombinant vaccines, Regulatory affairs, Side effects of vaccine, Therapeutic Vaccines, Transcriptional studies, TranslationVaccine, Immunology Vaccine types, Vaccine Vectors, Viral Immunology, etc.

We welcome articles from Professors, clinicians, scientists, research scholars and medical practitioners.We will publish all types of articles like clinical cases, case reports, research articles, review, short communication, commentarty, image articles, PPTs, letter to the Editor and Editorials.

Submit manuscript at www.opastpublishers.com/journal/current-research-in-vaccines-vaccination/manuscript-submission or send as an e-mail attachment to the Editorial Office at info@opastpublishers.com

Current Research in Vaccines Vaccination is an online open-access journal that provides an advanced forum for articles related to the all type of Vaccines. Following are some of the fields that the journal covers:

  • Immunology mechanisms
  • Polio vaccines
  • Animal models for immunologic diseases
  • Preclinical vaccine studies
  • Immunopathogenesis
  • Recombinant vector vaccines
  • Vaccine development and efficacy evaluation
  • TDAP vaccines
  • Immune responses to vaccines
  • Tuberculosis vaccines
  • Vaccine technology
  • Vaccination
  • Adjuvants and immunomodulators
  • Vaccine
  • Prophylactic vaccines
  • Vaccine adjuvants
  • Gene vaccines
  • Vaccine regulatory issues
  • Vaccines in bioterrorism
  • Vaccine research & development
  • Commercial utilization
  • Vaccines dermatology
  • Epidemiology
  • Vaccines epidemiology
  • Vaccinology
  • Vaccines immunology
  • Clinical research
  • Veterinary vaccines
  • Vaccine manufacturing
  • Immunology mechanisms
  • History
  • Animal models for immunologic diseases
  • Public policy
  • Pharmacology
  • Behavioral science and ethics
  • Toxicology and pharmaceutics
  • Social sciences
  • Biochemistry
  • Safety
  • Genetics
  • Discovery and basic science
  • Molecular biology and microbiology
  • Nonclinical development of vaccines
  • Influenza vaccine
  • Biodefense vaccine
  • Cholera vaccine
  • Aids vaccine
  • Bubonic plague vaccine
  • Vaccine formulation
  • Polio vaccine
  • Vaccine adjuvants and conjugate vaccines
  • Hepatitis a vaccine
  • Cancer/oncology vaccines
  • Rabies vaccine
  • Clinical evaluation of vaccines
  • Autoimmune disease
  • Vaccine safety
  • Bacteriology
  • Regulatory science
  • Cancer immunotherapy
  • Conventional and non-conventional vaccines
  • Epidemiology
  • Attenuated vaccines
  • Immunology
  • Inactivated vaccines
  • Immunomodulators
  • Subunit vaccines
  • Immunopathology
  • Toxoid vaccines
  • Immunopharmacology
  • DNA vaccines
  • Parasitology and virology
  • Recombinant vector vaccines
  • Vaccine technology
  • Vaccine immunology
  • Vaccine adjuvants
  • Vaccine research and immunization
  • Prophylactic vaccines
  • Component vaccines
  • Genetic vaccines
  • Ebola vaccines
  • AIDS vaccines and vaccines in bioterrorism
  • Characterization of immune responses
  • Genetics in treating human disease
  • Controlled challenge studies to assess vaccine efficacy
  • Gene-based therapy and drug delivery
  • Study of vaccine vectors
  • Development of new biocompatible delivery materials
  • Adjuvants and immunomodulators
  • Design of effective and safe vectors
  • Immune correlates of protection, and clinical trials
  • Applicability in the pharmaceutical and biotechnology community
  • Infectious diseases
  • HIV vaccines research & development
  • Non-communicable diseases
  • Human papillomavirus vaccine
  • Cancer vaccines
  • Immunotherapeutics
  • Chickenpox vaccines
  • MMR vaccines